Phase I Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Clinical trial NCT05533463 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05533463
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-21
- Primary completion
- 2024-06-25
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.